VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VIONQ) announced that it had received a response from the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment ("SPA") for its oncology therapeutic Onrigin™ (laromustine) Injection. In January 2010, Vion filed a SPA with the FDA...
VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VIONQ) announced that it had received a response from the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment ("SPA") for its oncology therapeutic Onrigin™ (laromustine) Injection. In January 2010, Vion filed a SPA with the FDA...
Ablynx [Euronext Brussels: ABLX], announced today that it has been awarded a grant worth EUR1.2 million by the Flemish agency for Innovation by Science and Technology (IWT). The grant supports Ablynx in accelerating the development of its Nanobody-based programme, ALX-0061, into clinical...
GlaxoSmithKline (GSK) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued two positive opinions in the European Union for two of its cancer medicines. The CHMP has issued a positive opinion for the authorisation of a new therapeutic...
GlaxoSmithKline (GSK) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued two positive opinions in the European Union for two of its cancer medicines. The CHMP has issued a positive opinion for the authorisation of a new therapeutic...
GlaxoSmithKline (GSK) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued two positive opinions in the European Union for two of its cancer medicines. The CHMP has issued a positive opinion for the authorisation of a new therapeutic...
Arcadia Biosciences, Inc., an agricultural technology company focused on developing technologies and products that benefit the environment and human health, today announced that it has received a two-year, $855,500 Small Business Technology Transfer (STTR) grant funded by the National Institute...
Arcadia Biosciences, Inc., an agricultural technology company focused on developing technologies and products that benefit the environment and human health, today announced that it has received a two-year, $855,500 Small Business Technology Transfer (STTR) grant funded by the National Institute...
Novus Scientific Pte. Ltd announced that the US Food and Drug Administration (FDA) has given the company 510(k) clearance to market the TIGR™ Matrix Surgical Mesh, for use in reinforcement of soft tissues where weakness exists. TIGR™ Matrix Surgical Mesh is a 100 percent resorbable, synthetic...
Former Los Angles Dodger and Boston Red Sox infielder Jose Offerman was banned for life by the Dominican Republic winter league for throwing a punch at an umpire, the Associated Press reports.Offerman, manager of the Licey Tigers, struck the first base umpire during an argument. He was arrested...
Former Los Angles Dodger and Boston Red Sox infielder Jose Offerman was banned for life by the Dominican Republic winter league for throwing a punch at an umpire, the Associated Press reports. Offerman, manager of the Licey Tigers, struck the first base umpire during an argument. He was arrested...
Former Los Angles Dodger and Boston Red Sox infielder Jose Offerman was banned for life by the Dominican Republic winter league for throwing a punch at an umpire, the Associated Press reports. Offerman, manager of the Licey Tigers, struck the first base umpire during an argument. He was arrested...
Clavis Pharma (OSE: CLAVIS); the Norwegian cancer drug development company, announced today that the US Food & Drug Administration (FDA) has granted orphan drug designation to CP-4126 for the treatment of pancreatic cancer. The designation follows the equivalent designation given by the European...
World Heart Corporation ("WorldHeart"; Nasdaq: WHRT), a developer of mechanical circulatory systems, announced that it has received unconditional approval from the U.S. Food and Drug Administration ("FDA") for the bridge-to-transplant ("BTT") study of the Levacor Ventricular Assist Device...
ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new model of the ZOLL E Series® Monitor/Defibrillator with carbon monoxide (CO) measurement...
A University of Maryland School of Medicine researcher will lead the coordinating center for a consortium of our nation's most prominent scientists in the field of stem cell research. Michael L. Terrin, M.D.,C.M.,M.P.H., professor of Epidemiology and Preventive Medicine, was chosen by the...
house but not in it. why? I live in a hilly neighborhood if that's helpful but i still get great signal when i leave my house to step outside. why is this??? how can i get signal indoors?
James A. Wells, professor and chairman of the department pharmaceutical chemistry at the University of California, San Francisco, and director of UCSF's small molecule discovery center, has been named the winner of the 2010 American Society for Biochemistry and Molecular Biology-Merck Award for...
Novartis announced that the European Commission (EC) has approved Onbrez Breezhaler (QAB149 or indacaterol) in both 150 mcg and 300 mcg doses as a new once-daily maintenance bronchodilator treatment of airflow obstruction in adult patients with chronic obstructive pulmonary disease (COPD)...
Researchers from the Pervasive Technology Institute Digital Science Center at Indiana University have begun work on an innovative project that will use cloud computing techniques to support life science research. The project is supported by a $1.5 million grant award from the National Institutes...